Literature DB >> 7670229

Pseudo-prolines (psi Pro) for accessing "inaccessible" peptides.

M Mutter1, A Nefzi, T Sato, X Sun, F Wahl, T Wöhr.   

Abstract

Pseudo-prolines (psi Pro) are introduced as a temporary protection technique for serine, threonine and cysteine side chains in standard Fmoc/tBu solid-phase peptide synthesis (SPPS). The incorporation of these novel building blocks into a growing peptide chain proceeds by means of the coupling of preformed, suitably protected psi Pro dipeptides. For the example of representative model peptides used in protein de novo design, the potential of psi Pro to solubilize otherwise sparingly or completely insoluble peptides is demonstrated. Because of their intrinsic propensity for preventing peptide aggregation and beta-sheet formation, pseudo-prolines offer new possibilities for accessing large peptides by convergent strategies and chemoselective ligation techniques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670229

Source DB:  PubMed          Journal:  Pept Res        ISSN: 1040-5704


  21 in total

1.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

2.  Mambalgin-1 Pain-relieving Peptide, Stepwise Solid-phase Synthesis, Crystal Structure, and Functional Domain for Acid-sensing Ion Channel 1a Inhibition.

Authors:  Gilles Mourier; Miguel Salinas; Pascal Kessler; Enrico A Stura; Mathieu Leblanc; Livia Tepshi; Thomas Besson; Sylvie Diochot; Anne Baron; Dominique Douguet; Eric Lingueglia; Denis Servent
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

3.  Methods and protocols of modern solid phase Peptide synthesis.

Authors:  Muriel Amblard; Jean-Alain Fehrentz; Jean Martinez; Gilles Subra
Journal:  Mol Biotechnol       Date:  2006-07       Impact factor: 2.695

4.  Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain.

Authors:  Yves-Marie Coïc; Francoise Baleux; Ömer Poyraz; Roman Thibeaux; Elisabeth Labruyere; Fabrice Chretien; Iradj Sobhani; Thierry Lazure; Benjamin Wyplosz; Gunter Schneider; Laurence Mulard; Philippe J Sansonetti; Benoit S Marteyn
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

Review 5.  Aligator: A computational tool for optimizing total chemical synthesis of large proteins.

Authors:  Michael T Jacobsen; Patrick W Erickson; Michael S Kay
Journal:  Bioorg Med Chem       Date:  2017-06-03       Impact factor: 3.641

6.  On the synthesis of conformationally modified peptides through isonitrile chemistry: implications for dealing with polypeptide aggregation.

Authors:  Xiangyang Wu; Peter K Park; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2011-05-03       Impact factor: 15.419

7.  Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V.

Authors:  N Budisa; C Minks; F J Medrano; J Lutz; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

8.  One-pot chemical synthesis of small ubiquitin-like modifier protein-peptide conjugates using bis(2-sulfanylethyl)amido peptide latent thioester surrogates.

Authors:  Emmanuelle Boll; Hervé Drobecq; Nathalie Ollivier; Annick Blanpain; Laurent Raibaut; Rémi Desmet; Jérôme Vicogne; Oleg Melnyk
Journal:  Nat Protoc       Date:  2015-01-15       Impact factor: 13.491

9.  Dicyclopropylmethyl peptide backbone protectant.

Authors:  Louis A Carpino; Khaled Nasr; Adel Ali Abdel-Maksoud; Ayman El-Faham; Dumitru Ionescu; Peter Henklein; Holger Wenschuh; Michael Beyermann; Eberhard Krause; Michael Bienert
Journal:  Org Lett       Date:  2009-08-20       Impact factor: 6.005

10.  Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).

Authors:  Mohammed Akhter Hossain; Ross A D Bathgate; Chze K Kong; Fazel Shabanpoor; Suode Zhang; Linda M Haugaard-Jönsson; K Johan Rosengren; Geoffrey W Tregear; John D Wade
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.